Article
Expert's Own Admissions Limit His Trial Testimony In DNJ Patent Case
A recent New Jersey decision shows how an expert's own deposition admissions can shrink his trial testimony. Treating qualification as a threshold question under amended Federal Rule of Evidence 702, the Court confined a pharmaceutical patent expert to his core field — even though no jury would hear the case.
Fox Rothschild LLP






















